New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments—such as monoclonal antibodies—sooner.
Ahmad Anouti, MD, a pediatric resident at UT Southwestern Medical Center, spoke with Healio about “clear-cut indicators” to differentiate between different types of autoimmune biliary diseases. He ...